GENECKER
Latest round
- Series C
Last raised
- Dec 2025
Total raised
- $18M
Investors
- 7
About GENECKER
a. GeneCker is a biotechnology company that conducts tests for cancer genomes, rare disease genomes, prenatal genomes, and individual genomes in order to provide personalized diagnosis, treatment, and health management methods., Ltd. and A Ventures. As of May 2025, Seong-hyeok Ye is the CEO of GeneCker. The company provides cloning services, such as gcFusion cloning (Insertion/Deletion/Domain Exchange), and gcFusion cloning (Mutagenesis) that allow plasmids to be produced in the desired structure; next generation sequencing, which includes mutation analysis service and illumine sequencing; and protein purification, a protein isolation and purification service by selecting optimal expression conditions with His tag, extensively applied tags for recombinant protein expression and purification. In addition, GeneCker develops CRISPR, a genome-testing platform.
Who invested in GENECKER
7 investors across 3 rounds
See all investors in GENECKER
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about GENECKER
Who invested in GENECKER?
GENECKER has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GENECKER raised?
GENECKER has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did GENECKER last raise money?
GENECKER's most recent round on record is a Series C, in Dec 2025.
What does GENECKER do?
GENECKER is a biotechnology company.
Where is GENECKER headquartered?
GENECKER is headquartered in Seoul, South Korea.
Which VCs invest in companies like GENECKER?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at GENECKER's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like GENECKER? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.